Fort Point Capital Partners LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Fort Point Capital Partners LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,360
-16.3%
17,0000.0%0.00%0.0%
Q2 2023$21,930
-2.3%
17,0000.0%0.00%0.0%
Q1 2023$22,440
-12.0%
17,0000.0%0.00%
-25.0%
Q4 2022$25,500
+27.5%
17,0000.0%0.00%
+33.3%
Q3 2022$20,000
+5.3%
17,0000.0%0.00%0.0%
Q2 2022$19,000
-62.7%
17,0000.0%0.00%
-57.1%
Q1 2022$51,000
+13.3%
17,0000.0%0.01%
+16.7%
Q4 2021$45,000
-27.4%
17,0000.0%0.01%
-33.3%
Q3 2021$62,000
-16.2%
17,0000.0%0.01%
-35.7%
Q2 2021$74,000
+27.6%
17,0000.0%0.01%
+16.7%
Q1 2021$58,000
-3.3%
17,0000.0%0.01%
-14.3%
Q4 2020$60,000
+46.3%
17,0000.0%0.01%
+40.0%
Q3 2020$41,000
+32.3%
17,0000.0%0.01%0.0%
Q2 2020$31,000
+14.8%
17,0000.0%0.01%
-16.7%
Q1 2020$27,000
-25.0%
17,0000.0%0.01%
-7.7%
Q4 2019$36,000
+12.5%
17,0000.0%0.01%
+8.3%
Q3 2019$32,000
-27.3%
17,0000.0%0.01%
-29.4%
Q2 2019$44,0000.0%17,0000.0%0.02%
-10.5%
Q1 2019$44,000
+12.8%
17,0000.0%0.02%
+18.8%
Q4 2018$39,000
-29.1%
17,0000.0%0.02%
-5.9%
Q3 2018$55,000
+14.6%
17,0000.0%0.02%
+6.2%
Q2 2018$48,000
-20.0%
17,0000.0%0.02%
-27.3%
Q1 2018$60,000
-9.1%
17,0000.0%0.02%
-29.0%
Q4 2017$66,000
+53.5%
17,0000.0%0.03%
+47.6%
Q3 2017$43,000
-6.5%
17,0000.0%0.02%
-19.2%
Q2 2017$46,00017,0000.03%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders